We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VIRI market cap is 107.56M. The company's latest EPS is USD -0.1908 and P/E is -20.28.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.27M | -1.14M | -1.31M | -1.07M | -2.3M |
| Net Income | -1.24M | -1.1M | -1.29M | -1.05M | -2.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.18M | -10.01M | -15.64M | -12.32M | -5.45M |
| Net Income | -2.47M | -10.35M | -15.96M | -12.25M | -5.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.25M | 4.17M | 3.23M | 3.64M | 2.28M |
| Total Liabilities | 487k | 358k | 570k | 500k | 1.33M |
| Total Equity | 4.76M | 3.81M | 2.66M | 3.14M | 949k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 316k | 31.47M | 15.78M | 8.37M | 4.17M |
| Total Liabilities | 5.26M | 1.53M | 1.28M | 1.04M | 358k |
| Total Equity | -5.02M | 29.94M | 14.5M | 7.33M | 3.81M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.4M | -4.87M | -937k | -1.75M | -2.66M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.16M | 1.16M | N/A | 1.45M | 1.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.09M | -3.9M | -15.69M | -11.47M | -4.87M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.37M | 33.38M | -97k | 4.49M | 1.16M |
| Market Cap | 107.56M |
| Price to Earnings Ratio | -20.28 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 32.38 |
| Price to Book Ratio | 28.22 |
| Dividend Yield | - |
| Shares Outstanding | 27.76M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -72.81% |
| 52 Week High | 23.50 |
| 52 Week Low | 3.15 |
| Spread (Intraday) | 0 (2.93%) |
| Company Name | Virios Therapeutics Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.virios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
